Corrigendum to 'Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50â¯years of age: A randomized trial' [Vaccine 36 (2018) 4278-4286].
Vaccine
; 37(9): 1252-1253, 2019 Feb 21.
Article
en En
| MEDLINE
| ID: mdl-30711316
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
Idioma:
En
Revista:
Vaccine
Año:
2019
Tipo del documento:
Article